Stock Information
ADC Therapeutics SA (ADCT)
Ticker Symbol: ADCT
Exchange: NYSE
Sector: N/A
Market Cap: $411.75 mil
Piotroski score: 4
PE Ratio: N/A
EPS (TTM): -1.5132
Revenue (TTM): $0.67 M
Dividend Yield: N/A%
ROE: -229.23%
Latest News
-
ADC Therapeutics to Participate in March Investor Conferences
Tue, Feb 24, 2026 12:15 PM
-
ADC Therapeutics Announces Amended HealthCare Royalty Financing Agreement
Mon, Feb 23, 2026 12:15 PM
-
ADC Therapeutics Cuts Change-of-Control Fee on ZYNLONTA Deal in New Royalty Agreement, Lowers Potential Payout to $150M Through 2027
Mon, Feb 23, 2026 8:18 AM
Key Financials
Financial data not available